Chimeric proteins and methods of immunotherapy
US11111287B2 · kind B2 · utility
1Cited by
28References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2019 |
| Grant date | Sep 7, 2021 |
| Priority date | — |
| Expiry date | Apr 17, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.